Pediatric Vaccine for COVID-19 Part 1 by P. Offit | OPENPediatrics

In this World Shared Practice Forum podcast, Dr. Paul Offit, Director of the Vaccine Education Center, co-inventor of the rotavirus vaccine, member of the FDA Vaccine Advisory Committee, and attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia, shares his perspective on issues relating to COVID-19 vaccination in children. He provides historical perspective on prior pediatric vaccine development efforts, and shares his insights into the appraisal of scientific evidence and decision-making processes that are involved in federal approval of the COVID-19 vaccines.   After this podcast, listeners will be able to: -Understand the challenges behind COVID-19 vaccination development for children from a historical perspective -Describe the available evidence relating to antibody-dependent enhancement and vaccine-associated enhancement of disease with the COVID-19 vaccines -Describe the considerations involved in federally approving COVID-19 vaccines for children Initial publication date: October 22, 2021 Citation: Offit P, Daniel D, Burns JP. Pediatric Vaccine for COVID-19 Part 1. 10/2021. Online Podcast. OPENPediatrics. https://soundcloud.com/openpediatrics/pediatric-vaccine-for-covid-19-part-1-by-dr-paul-offit-for-openpediatrics. Please visit: http://www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children’s Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open access-and thus at no expense to the user. For further information on how to enroll, please email: [email protected]